2016 China's gene sequencing industry development status and business layout analysis (graphic)

The gene sequencing industry is developing rapidly, and the second generation sequencing is the mainstream technology. Nowadays, the first-generation gene sequencing technology has been unable to meet the needs of research and application due to low throughput and long sequencing time. The second-generation sequencing technology featuring high-throughput and low-cost is the most widely used sequencing technology, and the sequencing time phase Compared with the first generation technology is greatly reduced. As an important part of precision medicine , gene sequencing has developed rapidly in recent years with the advancement of technology and cost. According to BBCRESERCH, it has grown from 794 million US dollars in 2007 to 4.5 billion US dollars in 2013, with a compound growth rate of 33.5. %, it is expected to maintain rapid growth in the next few years, reaching $11.7 billion in 2018, with a compound growth rate of 21.1%.

The support of national policies and the continuous breakthrough of technology are the two cornerstones for supporting the vigorous development of gene sequencing in the future. Gene detection is the extraction and sequencing of gene sequences from human blood, body fluids or cells. Usually, the detection of cancer-related genes may indicate the potential for disease. Gene detection technology includes FISH, PCR, gene chip and sequencing technology. Among them, sequencing technology has attracted the most attention, and after four generations of innovation and development, it has reached the level of clinical popularization and application in terms of cost, flux level and accuracy. In terms of policies, the state has announced a series of pilot units and invested in research funding to support research, and is vigorously promoting the genetic industry to reach the international advanced level.

Third Generation Sequencing--Pacbio Sequencing Principle and Platform Features

Gene sequencing technology will become the core platform for future molecular diagnosis. From the market capacity and annual compound growth rate of genetic testing, second-generation sequencing and digital PCR have maintained a 50% market growth rate. In the future, as the level of sequencing technology increases, costs decrease, and computing power increases, sequencing technology will achieve more than $3.4 billion in market capacity in 2017.

Silicone Gel Applicator MDK-SGA-04

China Silicone Dressing Wound,Precision Silicone Applicator,Dual Silicone Applicator,Silicone Based Dressing, we offered that you can trust. Welcome to do business with us.

Silicone Dressing Wound,Precision Silicone Applicator,Dual Silicone Applicator,Silicone Based Dressing

Henan Maidingkang Medical Technology Co.,Ltd , https://www.mdkmedical.com